Recce Pharmaceuticals – executive interview

Recce Pharmaceuticals – executive interview

Recce Pharmaceuticals — 1 video in collection

More on this equity

Recce Pharmaceuticals (ASX: RCE) is a clinical-stage pharmaceutical company headquartered in New South Wales, Australia. It is a developing a new class of synthetic anti-infectives with novel mechanisms of action suited for treating multi-drug resistant bacteria and emerging viral pathogens. Recce’s lead candidate, RECCE 327, is being investigated for the treatment of sepsis and burn wound infections.

In this video, James Graham, Recce’s chief executive officer, explains what sets Recce apart from other antibiotic developers.


You may also be interested in these:

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free